
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi".
Filed with NSE ·

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi".
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories